Genetically removing p16-expressing senescent glial cells has been demonstrated to alleviate cognitive decline, reduce tau hyperphosphorylation, and prevent gliosis in a tauopathy mouse model [18]. The gene discussed is MAPT; the disease is Mental deterioration.